Business
Cognition Therapeutics Announces Participation in 21st Annual Needham Virtual Healthcare Conference
PURCHASE, N.Y., April 06, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage neuroscience company developing drugs to
About this update from Cognition Therapeutics, Inc.
[{"type":"text","content":"PURCHASE, N.Y., April 06, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage neuroscience company developing drugs to treat age-related degenerative diseases of the central nervous system and retina, today announced that the company would be participating in Needham & Company’s 21st Annual Virtual Healthcare Conference being held April 11-14, 2022. The Company’s president and CEO, Lisa Ricciardi, will be providing a corporate update on Monday, April 11, 2022 from 3:00 – 3:40 p.m. ET. A live and archived webcast will be available on the Investors section of the company’s website at https://ir.cogrx.com. In addition, Ms. Ricciardi will be available for one-on-one meetings during the conference. To schedule a one-on-one meeting, please contact your Needham & Co. representative. About Cognition TherapeuticsCognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system, or CNS, and retina. Our goal is to develop disease modifying treatments for patients with these degenerative disorders by initially leveraging our expertise in the sigma-2 (σ-2) receptor, which is expressed by multiple cell types, including neuronal synapses, and acts as a key regulator of cellular damage commonly associated with certain age-related degenerative diseases of the CNS and retina. We believe that targeting the σ-2 receptor complex represents a mechanism that is functionally distinct from other current approaches in clinical development for the treatment of degenerative diseases. For more information, visit https://cogrx.com. Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this press release, other than statements of historical facts or statements that relate to present facts or current conditions, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking ...